Announcements Trials
Browse Landscape

Phase

Phase 2 10Phase 1 8Phase 1/2 3Phase EARLY_PHASE1 1

Status

Withdrawn 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1Head & Neck 1Dermatologic 1

Conditions

Melanoma 9Squamous Cell Carcinoma of Head and Neck 3Skin Neoplasms 3Sarcoma 2Pancreatic Neoplasms 2Head and Neck Neoplasms 2Carcinoma, Renal Cell 2Carcinoma, Non-Small-Cell Lung 2Brain Neoplasms 2Sarcoma, Kaposi 1Pinealoma 1Neoplasms, Germ Cell and Embryonal 1Neoplasm Metastasis 1Muscle Invasive Bladder Urothelial Carcinoma 1Motor Activity 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Lymphoid Interstitial Pneumonia 1Liver Neoplasms 1Laryngeal Diseases 1Hodgkin Disease 1Glioma 1Colorectal Neoplasms 1Central Nervous System Neoplasms 1Carcinoma, Merkel Cell 1Carcinoma, Hepatocellular 1Carcinoma, Basal Cell 1Borderline Resectable Pancreatic Adenocarcinoma 1Acquired Immunodeficiency Syndrome 1

Interventions

Rituximab 5fludarabine 4Cyclophosphamide 4pembrolizumab 2Bendamustine Hydrochloride 268Ga-pentixafor 2venetoclax 1pegylated granulocyte colony-stimulating factor, human 1pegfilgrastim 1motexafin gadolinium 1ibrutinib 1fludarabine phosphate 1daratumumab 1brexucabtagene autoleucel 1acalabrutinib 1Vincristine 1Valproic Acid 1Transplantation 1Tablets 1Surveys and Questionnaires 1Sugars 1Stem Cell Transplantation 1Simvastatin 1Roflumilast 1Ribavirin 1Radiotherapy 1Procarbazine 1Positron-Emission Tomography 1Pemetrexed 1Nivolumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Lymphoma × Nivolumab × Clear all
NCT04891718 2022-07-08

CIVO Intratumoural Microdosing of Anti-Cancer Therapies in Australia

Presage Biosciences

Phase EARLY_PHASE1 Withdrawn
DermatologicHead & NeckLymphoidSarcoma

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Lymphoma, Melanoma, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡